Skip to main content
. 2022 Jul 22;51:101569. doi: 10.1016/j.eclinm.2022.101569

Figure 3.

Figure 3

Anti-SARS-CoV-2 receptor-binding domain (RBD) IgG antibody response. Geometric mean concentrations of anti-SARS-CoV-2 RBD IgG were compared from baseline (day 0) to day 56 (28 days after the second dose). BAU, binding antibody unit; GMC, Geometric mean concentration; SD, standard deviation; SCR, seroconversion rate; NIBSC, National Institute for Biological Standards and Control; HCS, human convalescent serum.